regulus therapeutics inc
(RGLS:NASDAQ GM)
Last $7.14 USD
Change Today +0.09 / 1.28%
Volume 75.3K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Insiders at regulus therapeutics inc (RGLS)
| Name (Connections) | Board Relationships | Title | Type of Board Member | Age |
| Kleanthis Xanthopoulos Ph.D. | 142 Relationships | Chief Executive Officer, President and Director | -- | 54 |
Other Board Members on Board*
| Name (Connections) | Board Relationships | Type of Board Member | Primary Company | Age |
| John Maraganore Ph.D. | 182 Relationships | -- | Alnylam Pharmaceuticals, Inc. | 49 |
| David Baltimore Ph.D. | 118 Relationships | -- | Ariad Pharmaceuticals Inc. | 74 |
| B. Parshall Esq., J.D. | 50 Relationships | -- | Isis Pharmaceuticals, Inc. | 56 |
| Stelios Papadopoulos Ph.D. | 104 Relationships | -- | Exelixis, Inc. | 64 |
| David Bartel Ph.D. | 27 Relationships | -- | Regulus Therapeutics Inc. | -- |
| Markus Stoffel M.D., Ph.D. | 25 Relationships | -- | PanCel Corporation | -- |
| Thomas Tuschl Ph.D. | 24 Relationships | -- | Alnylam Pharmaceuticals, Inc. | -- |
| Gregory Hannon Ph.D. | 15 Relationships | -- | Regulus Therapeutics Inc. | -- |
| Bruce Carter Ph.D. | 199 Relationships | -- | Immune Design Corp. | 69 |
| Douglas Williams Ph.D. | 63 Relationships | -- | Biogen Idec Inc. | 54 |
| Mark Foletta CPA | 19 Relationships | -- | Amylin Pharmaceuticals, Inc. | 51 |
| William Rastetter Ph.D. | 77 Relationships | -- | Receptos, Inc. | 64 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| RGLS:US | $7.14 USD | +0.09 |  |
| Company | Last | Change |
| Arrowhead Research Corp | $2.18 USD | -0.03 |
| Benitec Biopharma Ltd | A$0.02 AUD | 0.00 |
| Enzon Pharmaceuticals Inc | $3.07 USD | -0.07 |
| Silence Therapeutics PLC | 185.00 GBp | -12.00 |
| Tekmira Pharmaceuticals Corp | C$4.85 CAD | -0.05 |
| View Industry Companies | ||
Industry Analysis
RGLS
Industry Average
| Valuation | RGLS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 20.1x |
|
| Price/Book | 4.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 12.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
